PREVORA STAGE 1 SOLUTION

Maa: Kanada

Kieli: englanti

Lähde: Health Canada

Aktiivinen ainesosa:

CHLORHEXIDINE ACETATE

Saatavilla:

CHX TECHNOLOGIES INC

ATC-koodi:

A01AB03

INN (Kansainvälinen yleisnimi):

CHLORHEXIDINE

Annos:

10%

Lääkemuoto:

SOLUTION

Koostumus:

CHLORHEXIDINE ACETATE 10%

Antoreitti:

DENTAL

Kpl paketissa:

1.0ML

Prescription tyyppi:

Prescription

Terapeuttinen alue:

DENTAL AGENTS

Tuoteyhteenveto:

Active ingredient group (AIG) number: 0107805006; AHFS:

Valtuutuksen tilan:

APPROVED

Valtuutus päivämäärä:

2001-08-02

Valmisteyhteenveto

_PREVORA STAGE 1 Product Monograph Page 1 of 17 _
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
PR
PREVORA STAGE 1
Chlorhexidine acetate
Dental solution, 10% w/v
Antimicrobial agent
CHX Technologies Inc.
4800 Dundas Street West,
Suite 105,
Toronto, ON
M9A 1B1
Date of Revision:
August 17, 2017
Submission Control No: 204666
_PREVORA STAGE 1 Product Monograph Page 2 of 17 _
_ _
_ _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................3
ADVERSE REACTIONS
....................................................................................................4
DRUG INTERACTIONS
....................................................................................................4
DOSAGE AND ADMINISTRATION
................................................................................5
OVERDOSAGE
..................................................................................................................8
STORAGE AND STABILITY
............................................................................................8
DOSAGE FORMS, COMPOSITION AND PACKAGING
...............................................9
PART II: SCIENTIFIC INFORMATION
...............................................................................10
PHARMACEUTICAL INFORMATION
..........................................................................10
DETAILED PHARMACOLOGY
.....................................................................................11
MICROBIOLOGY
............................................................................